ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

NKTR Nektar Therapeutics

1.12
-0.05 (-4.27%)
18 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Nektar Therapeutics NKTR NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.05 -4.27% 1.12 18:59:09
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.16 1.11 1.16 1.14 1.17
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/6/202417:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202415:11EDGAR2Form 144 - Report of proposed sale of securities
12/6/202408:30PRNUSNektar Therapeutics Presents First Preclinical Data on..
06/6/202415:05EDGAR2Form 8-K - Current report
05/6/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
05/6/202416:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/5/202417:00PRNUSNektar Management to Present at Upcoming Investor..
28/5/202415:51EDGAR2Form S-3 - Registration statement under Securities Act of..
20/5/202420:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202420:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202420:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202415:25EDGAR2Form 144 - Report of proposed sale of securities
17/5/202415:22EDGAR2Form 144 - Report of proposed sale of securities
17/5/202415:14EDGAR2Form 144 - Report of proposed sale of securities
13/5/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202415:20EDGAR2Form 8-K - Current report
09/5/202415:15PRNUSNektar Therapeutics Reports First Quarter 2024 Financial..
02/5/202417:00PRNUSNektar to Announce Financial Results for the First Quarter..
22/3/202413:00PRNUSNektar Management to Present at the H.C. Wainwright 2nd..
05/3/202416:11EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202408:00PRNUSNektar Therapeutics Announces Initiation of Phase 2b..
04/3/202415:20EDGAR2Form 8-K - Current report
04/3/202415:15PRNUSNektar Therapeutics Reports Fourth Quarter and Year-End 2023..
04/3/202407:40EDGAR2Form 8-K - Current report
04/3/202407:30PRNUSNektar Therapeutics Announces $30 Million Private Placement..
27/2/202417:00PRNUSNektar Management to Present at the TD Cowen 44th Annual..
26/2/202417:00PRNUSNektar to Announce Financial Results for the Fourth Quarter..
22/2/202419:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202419:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202419:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202414:55EDGAR2Form 144 - Report of proposed sale of securities
20/2/202414:51EDGAR2Form 144 - Report of proposed sale of securities
20/2/202414:50EDGAR2Form 144 - Report of proposed sale of securities
16/2/202416:16EDGAR2Form 8-K - Current report
14/2/202416:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202407:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/1/202415:25EDGAR2Form 8-K - Current report
03/1/202417:00PRNUSNektar Management To Present at the 42nd Annual J.P. Morgan..
15/12/202317:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202317:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202317:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202311:18EDGAR2Form 144 - Report of proposed sale of securities
11/12/202317:00PRNUSNektar and Collaborators Present Preclinical Data on..
27/11/202315:55EDGAR2Form 8-K - Current report
20/11/202320:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202320:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202319:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202315:36EDGAR2Form 144 - Report of proposed sale of securities
17/11/202315:15EDGAR2Form 144 - Report of proposed sale of securities
17/11/202315:10EDGAR2Form 144 - Report of proposed sale of securities

Su Consulta Reciente

Delayed Upgrade Clock